After US$195 million in talc verdicts, J&J strives to change court

After US$195 million in talc verdicts, J&J strives to change court


After a US$67.5 million jury verdict against Johnson & Johnson on Oct. 27 marked its third straight trial defeat in an onslaught of lawsuits claiming its talc-based products cause ovarian cancer, the company is hoping to reverse the trend by having the cases heard in a different court. A bottle of Johnson and Johnson Baby Powder is seen in a photo illustration taken in New York, February 24, 2016.



from Biotech News